Nosocomial infection

From April 1^st, 2013, to March 31^st, 2014, 77 healthcare facilities took part on a voluntary basis in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,149,763 patient-days (Table 1). Participating facilities reported 2,689 BSIs in 2,495 patients. The total incidence rate was 5.4 cases per 10,000 patient-days. The incidence rate in 2013-2014 was significantly lower compared…

From April 1, 2013, to March 31, 2014, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,948,058 patient days (Table 1). In total, 92 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.19 / 10…

From April 1, 2013, to March 31, 2014, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,121,300 inpatient days. The participating facilities reported 3,661 cases of healthcare-associated (HA) CDAD. The incidence rate of HA CDAD was 7.1 cases per 10,000 patient days. This incidence rate was stable compared to the rate of 2012–2013. The 10-day…

From April 1, 2013, to March 31, 2014, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,939,160 inpatient days. Together, these facilities reported 97 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years. The proportion of…

From April 1, 2012, to March 31, 2013, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (HA-VRE) infections, for a combined total of 5,017,791 patient days. In total, 41 cases of VRE infection were reported among patients who contracted the strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of HA-VRE infection (cat. 1a + 1b) was 0.08/10,000…

From April 1, 2012, to March 31, 2013, 88 healthcare facilities took part in the surveillance of methicillinresistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 5,011,231 patient days. Together, these facilities reported 147 cases of healthcare-associated MRSA bloodstream infections. The incidence rate was 0.29/10,000 patient days. This incidence rate has declined over the past five years. The proportion of methicillin…

From April 1, 2012, to March 31, 2013, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,233,966 inpatient days. The participating facilities reported 3,797 cases of healthcare-associated (HA) CDAD. The total incidence rate of HA-CDAD was 7.3 cases per 10,000 patient days. This incidence rate was stable compared to the rate of 2011–2012. The 10-day case fatality was 8.7% (n=304…

Entre le 1^er avril 2012 et le 31 mars 2013, 64 installations de santé ont participé sur une base volontaire à la surveillance des bactériémies panhospitalières, pour un cumul de 3 797 385 joursprésence (tableau 1). Ces installations ont rapporté 2 797 bactériémies, survenues chez 2 674 patients. Le taux d'incidence total était de 6,1 cas par 10  000 joursprésence. Le taux d'incidence en 2012-2013 a diminué…

From April 1, 2012, to March 31, 2013, 67 intensive care units (ICUs) took part in the surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,207 centralline days. Participating ICUs reported 201 CLABSIs in 197 patients. Incidence rates were 1.13 per 1,000 central-line days in coronary ICUs, 0.84 in teaching adult ICUs, 1.22 in non-teaching adult ICUs, 2.83 in pediatric ICUs and 5.36 in neonatal ICUs. Incidence rates in…

From April 1, 2012, to March 31, 2013, 42 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 51,697 patient periods. The participating units reported 218 VARBSIs in 209 patients. Patient periods involving a fistula accounted for 44.9% of cases. The VARBSI incidence rate was 0.19 cases per 100 patient periods for patients with an…